Investors
Information Disclosure
-
NEXT DAY DISCLOSURE RETURN2022.01.31
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.01.27
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.01.26
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.01.25
-
VOLUNTARY ANNOUNCEMENT - APPROVAL OF "ADALIMUMAB SOLUTION FOR INJECTION" FOR MARKETING2022.01.20
-
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE FIRST GENERIC "SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLETS" FOR MARKETING2022.01.10
-
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 20212022.01.03
-
NEXT DAY DISCLOSURE RETURN2021.12.29